Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bardazzi

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 11, 2020
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experienceM C Fargnoli, M Esposito, P Dapavo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 30, 2024
Long-term effectiveness and tolerability of apremilast in patients with moderate-to-severe plaque psoriasis: A 5-year multicentre retrospective study-IL PSO (Italian landscape psoriasis)L Gargiulo, L Ibba, P Malagoli, et al.
The British Journal of Dermatology|December 23, 2018
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experienceA Conti, F Peccerillo, P Amerio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2022
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian studyF Bardazzi, F Filippi, M A Chessa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2023
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS)L Gargiulo, L Ibba, P Malagoli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 7, 2023
PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapyL Sacchelli, F Filippi, A Balato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2020
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in ItalyM Talamonti, M Galluzzo, A Chiricozzi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 26, 2024
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER studyC Bonifati, S Lembo, A G Richetta, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 29, 2014
Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioningP Gisondi, P Amerio, G F Amoroso, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 11, 2020
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experienceM C Fargnoli, M Esposito, P Dapavo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 30, 2024
Long-term effectiveness and tolerability of apremilast in patients with moderate-to-severe plaque psoriasis: A 5-year multicentre retrospective study-IL PSO (Italian landscape psoriasis)L Gargiulo, L Ibba, P Malagoli, et al.
The British Journal of Dermatology|December 23, 2018
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experienceA Conti, F Peccerillo, P Amerio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2022
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian studyF Bardazzi, F Filippi, M A Chessa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2023
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS)L Gargiulo, L Ibba, P Malagoli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 7, 2023
PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapyL Sacchelli, F Filippi, A Balato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2020
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in ItalyM Talamonti, M Galluzzo, A Chiricozzi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 26, 2024
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER studyC Bonifati, S Lembo, A G Richetta, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 29, 2014
Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioningP Gisondi, P Amerio, G F Amoroso, et al.
Pageof 16